Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
Prophylactic administration of metabolically active insulin can prevent or delay clinical
onset of diabetes in a high risk group of nondiabetic siblings as defined by positivity for
autoantibodies against IA-2 (IA-2-A).